With 29,680 votes cast on CalledIt, the community has a clear view on "Will FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share break its current traffic record this week?". The split stands at 68% YES. Here's what the data says and why it matters.
Trending topic: FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share. <ol><li><a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPUHE5M3dUeHNPQnlIVm9OS3RQOFVpTzRLdk5WdHN3SkF0SUVTWUtEaDJ1ZmloSHRHNk9YOGFXXzVFNWY3TmY5LV83aG95czFnM3FUZEdreXlTSVVnV0ZHODB0SVRnajdfV2h2OFJxRDlZUV9QbkFsNEFlb1dKQWhfZUJTd2FBWkg0NEsySGJRbHpEZklSak8yQ2Ffd0Z2b0laVHB2YXk5c9IBrAFBVV95cUxPT3dRMlpUbFdCNU9FblVvZHhmYWdXczVsQjBJUTNSbW0zWUI5RnlIVi1BaFBydy1PVGdSMGQ3dlZTZ3RWSTVka0VWVDFnTjkwWEp3bUpzb011NDhoR3JtdmF5OWdjSDZNMHpPc2t3Y3dITHRIQy1iRmt6MFJGRU03UTZSVGxYMmNITW1fTkRwQi0wNzk1RWp5b3ZxdXFYWmt6WnRXWVFYWTVhWlY4?oc=5" target="_blank">FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share</a> <font color="#6f6f6f">CNBC</font></li><li><a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE9RR25yR2w3eUNWTC04X1k1S0ZiZlhfcllKOWl2U1ZvekFaVXFUXzBIWGwyWkVkR042cWJHM0xCWW5zbm84aldIRkZ6RWdSZi04dHR1WTBEMjlBdnAzeU1qcnlKUTVRTzZXTkloeHp3?oc=5" target="_blank">Weight-loss treatment is on the verge of a dramatic shift – again</a> <font color="#6f6f6f">CNN</font></li><li><a href="https://news.google.com/rss/articles/CBMifkFVX3lxTE44ck5ZMTA0QTBnZmpLQnpmWnV5dFJNbzZSaUEzNmlhNG1sUUU3SG8xTFRxRi1uSlNHUk4wa0xkaUk5VER0RDk3SWNUeVFid1FPTzlRRXdNcWE0TDdTakpzOFhxZmRDMU9WWks5MVJtRWwwMEppbFRYNG42VXBkd9IBgwFBVV95cUxONXpBX3ltdjFMTnNNT2pmMmxxTXdacjNtdnBrTkJsXzNRcjFhOUxpNk9SVTlTMVpTYVU0aXZhNnBrSUtlYTBqMkN5WjQyMW1LbnFQb3RwRnVjcHEwZzh4MGt6X0ctalNxNjJIbTdMdjhXaUt4VUJqZFV1a0RnUTJsTUI0QQ?oc=5" target="_blank">FDA approves higher dose of Wegovy</a> <font color="#6f6f6f">The Hill</font></li><li><a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxPakoxbkM0TG81aS1OZmh5ZWUtSUVIX2pvZkxFaGNHYUFVN3VVVklmb2dsc3VMX1VtWTJpNlZlX0JhU0NDT0RDb18wRFpNblF6SmIzdnlDdkgwemlyMW05WlJCdkNWU2VTbVdnUjhoemVEQnZJbjlIVVlxSnk2TnlTTDFFWS13cWxoYjcwcm55bUl4WXFYV0NBUlAxckJEMTdxVFh4MHN5a3gxWEZyUXhkMWtucTNad1ZmRW1maTFlS0E3cGtqaGh3?oc=5" target="_blank">Novo’s Wegovy HD passes muster under FDA national priority voucher program</a> <font color="#6f6f6f">Fierce Pharma</font></li><li><a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxOck4tZjlVWDJWZHFEWXZrc0pCakdVQXRfTzhZTUg1Z01XUG4tRDVKaFQtTzV3by1QUFRFNWVWVGNZN3Q1SVIzV0NFQnlfSXd3Q0VKcTVFanlzdzdGT2xCWVlteHhEWkJUY2paazFtNmRIaEJIS001R1RVMnpjbUhLOWFwQTlxUVBYYm9JRHAwSy1FMEI5SzVRNUo4RmxYeWtGTUdXU3R3UW1tcjZDUndpVWdtUFhTUVhMV0ZqQ3lKMFQ?oc=5" target="_blank">A high dose of Wegovy helped people lose 21% of their weight. It was just approved.</a> <font color="#6f6f6f">MarketWatch</font></li></ol> This prediction has attracted a large and engaged voting community on CalledIt, reflecting broad public interest in the outcome. Community predictions on CalledIt have historically been competitive with expert forecasts on similar questions.
Breaking down the numbers: 68% of 29,680 voters say YES, while 32% say NO. This 36-point gap represents meaningful optimism — not just a coin flip.Large-sample community prediction data of this kind has been shown in academic research to be surprisingly accurate. The wisdom-of-crowds effect means that 29,680 independent assessments tend to cancel out individual biases, leaving a more reliable signal than expert opinion alone.
Based on 29,680 community votes, the CalledIt verdict is YES at 68%. The community expects this to happen, and the strength of the consensus suggests meaningful confidence.Want to cast your own vote and track how the community consensus shifts as we approach Mar 29, 2026? Download CalledIt to vote, stake Vibe Points, and see the live prediction breakdown.
This prediction was crowd-sourced via the CalledIt App.
Top comments (0)